These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3709051)

  • 1. Conformation therapy: a method of improving the tumour treatment volume ratio.
    Tate T; Brace JA; Morgan H; Skeggs DB
    Clin Radiol; 1986 May; 37(3):267-71. PubMed ID: 3709051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment planning for heavy ion radiotherapy.
    Chen GT; Singh RP; Castro JR; Lyman JT; Quivey JM
    Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1809-19. PubMed ID: 118947
    [No Abstract]   [Full Text] [Related]  

  • 3. FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses.
    Nkhali L; Thureau S; Edet-Sanson A; Doyeux K; Benyoucef A; Gardin I; Michel P; Vera P; Dubray B
    Acta Oncol; 2015 Jun; 54(6):909-15. PubMed ID: 25417733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PET in target localization for radiotherapy treatment planning.
    Rembielak A; Price P
    Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
    Vrieze O; Haustermans K; De Wever W; Lerut T; Van Cutsem E; Ectors N; Hiele M; Flamen P
    Radiother Oncol; 2004 Dec; 73(3):269-75. PubMed ID: 15588870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CT scanning in the radiotherapy planning of pelvic tumors.
    Badcock PC
    Int J Radiat Oncol Biol Phys; 1983 Jun; 9(6):905-9. PubMed ID: 6863063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Deep-seated tumors: is combined radiotherapy advantageous?].
    Rofo; 1997 Nov; 167(5):M38. PubMed ID: 9440882
    [No Abstract]   [Full Text] [Related]  

  • 8. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung.
    Graham MV; Matthews JW; Harms WB; Emami B; Glazer HS; Purdy JA
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1105-17. PubMed ID: 8083080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer.
    Cominos M; Mosleh-Shirazi MA; Tait D; Henrys A; Cornes P
    Br J Radiol; 2005 Dec; 78(936):1069-74. PubMed ID: 16352580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT.
    Gabryś D; Kulik R; Trela K; Ślosarek K
    Radiother Oncol; 2011 Sep; 100(3):360-4. PubMed ID: 21974916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A constrained least-squares optimization method for external beam radiation therapy treatment planning.
    Starkschall G
    Med Phys; 1984; 11(5):659-65. PubMed ID: 6548791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume reduction versus radiation dose for tumors in previously untreated lymphoma patients who received iodine-131 tositumomab therapy. Conjugate views compared with a hybrid method.
    Koral KF; Francis IR; Kroll S; Zasadny KR; Kaminski MS; Wahl RL
    Cancer; 2002 Feb; 94(4 Suppl):1258-63. PubMed ID: 11877754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
    Hsu A; Pawlicki T; Luxton G; Hara W; King CR
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
    Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
    Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk.
    Ahmed RS; Kim RY; Duan J; Meleth S; De Los Santos JF; Fiveash JB
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):505-12. PubMed ID: 15380585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation tolerance dose of the spinal cord following conventionally fractionated irradiation].
    Yamada S; Hoshi A; Takai Y; Hoshino F; Mochizuki Y; Kanehira C; Kaneta K
    Gan No Rinsho; 1987 Aug; 33(10):1189-92. PubMed ID: 3669312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the lumbosacral plexus-contouring protocol developed by Yi et al. (IJROBP 2012; 84: 376-82) for pelvic malignancies.
    Min M; Roos D; Keating E; Kerr L; Mukherjee R; Potter A; Shakeshaft J; Baxi S
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):117-24. PubMed ID: 24529065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma.
    Lee YK; Cook G; Flower MA; Rowbottom C; Shahidi M; Sharma B; Webb S
    Radiother Oncol; 2004 Dec; 73(3):277-83. PubMed ID: 15588871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and anatomical guidelines in pelvic cancer contouring for radiotherapy treatment planning.
    Portaluri M; Bambace S; Perez C; Giuliano G; Angone G; Scialpi M; Pili G; Didonna V; Alloro E
    Cancer Radiother; 2004 Aug; 8(4):222-9. PubMed ID: 15450515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.